Peptron

087010.KQ

63.35 USD

-0.79

-1.23%

Overview

Last close

63.35 usd

Market cap

970.89M usd

52 week high

93.86 usd

52 week low

16.05 usd

Target price

24.42 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

789.073

Price/Book Value

103.6019

Enterprise Value

1.50B usd

EV/Revenue

894.5417

EV/EBITDA

-17.5233

Key financials

Revenue TTM

4.05M usd

Gross Profit TTM

3.12M usd

EBITDA TTM

-7.49M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

30.31M usd

Net debt

N/A usd

About

Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, and puberty; SR-Octreotide for the treatment of acromegaly; SR-Exenatide to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.